CSIMarket


Hutchmed china Limited  (NASDAQ: HCM)
Other Ticker:  
 

Hutchmed china Limited

HCM's Fundamental analysis








Hutchmed China Limited's sales fell by -24.8 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 135

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Hutchmed China Limited's net profit decreased by -62.24 % in fourth quarter of 2024 year on year, to $38 millions.

More on HCM's Growth


Hutchmed China Limited
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Hutchmed China Limited realized cash reduction of $ -0.29 per share in trailing twelve-month period.
Company
330.5
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.


More on HCM's Valuation
 
 Total Debt (Millions $) 83
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,349,467
 Net Income/Employee (TTM) $ 81,734
 Receivable Turnover (TTM) 4.05
 Tangible Book Value (Per Share $) 0.88

Hutchmed China Limited
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Hutchmed China Limited realized cash outflow of $ -0.29per share in trailing twelve-month period.
Company
330.5
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.

Hutchmed China Limited Price to Book Ratio is at 14.95 lower than Industry Avg. of 33.1. and higher than S&P 500 Avg. of 0.01

More on HCM's Valuation

  Market Capitalization (Millions $) 11,539
  Shares Outstanding (Millions) 873
  Employees 467
  Revenues (TTM) (Millions $) 630
  Net Income (TTM) (Millions $) 38
  Cash Flow (TTM) (Millions $) -256
  Capital Exp. (TTM) (Millions $) -18
  Total Debt (Millions $) 83
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,349,467
  Net Income/Employee(TTM) $ 81,734
  Receivable Turnover Ratio (TTM) 4.05
  Tangible Book Value (Per Share $) 0.88

  Market Capitalization (Millions $) 11,539
  Shares Outstanding (Millions) 873
  Employees 467
  Revenues (TTM) (Millions $) 630
  Net Income (TTM) (Millions $) 38
  Cash Flow (TTM) (Millions $) -256
  Capital Exp. (TTM) (Millions $) -18





  Ratio
   Capital Ratio (MRQ) 2.83
  Total Debt to Equity (MRQ) 0.11
  Tangible Leverage Ratio (MRQ) 0.67
  Asset Turnover Ratio (TTM) 0.49
  Inventory Turnover Ratio (TTM) 6.92





Hutchmed China Limited net profit margin of 6.06 % is currently ranking no. 53 in Major Pharmaceutical Preparations industry, ranking no. 154 in Healthcare sector and number 1775 in S&P 500.

More on HCM's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com